Paolo Cameli

6.2k total citations
162 papers, 2.3k citations indexed

About

Paolo Cameli is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Paolo Cameli has authored 162 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Pulmonary and Respiratory Medicine, 72 papers in Physiology and 20 papers in Epidemiology. Recurrent topics in Paolo Cameli's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (92 papers), Sarcoidosis and Beryllium Toxicity Research (48 papers) and Asthma and respiratory diseases (20 papers). Paolo Cameli is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (92 papers), Sarcoidosis and Beryllium Toxicity Research (48 papers) and Asthma and respiratory diseases (20 papers). Paolo Cameli collaborates with scholars based in Italy, Germany and United Kingdom. Paolo Cameli's co-authors include Elena Bargagli, Laura Bergantini, Miriana d’Alessandro, Piersante Sestini, Rosa Metella Refini, Paola Rottoli, Maria Pieroni, Claudia Landi, Matteo Cameli and Lucia Vietri and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Paolo Cameli

145 papers receiving 2.3k citations

Peers

Paolo Cameli

PRM

PHYSI

CCM

Huaping Dai China

Elisabetta Balestro Italy

Corrado Campochiaro Italy

Jang Soo Suh South Korea

Seung Ick South Korea

J.F. Cordier France

Laura Bergantini Italy

Pearl Toy United States

Henk J.T. Ruven Netherlands

Jérôme Le Pavec France

Huaping Dai China

Paolo Cameli

1.4k ×1.0

PRM

376 ×0.5

PHYSI

90 ×0.3

594 ×2.1

185 ×0.7

CCM

Citations per year, relative to Paolo Cameli Paolo Cameli (= 1×) peers Huaping Dai

Countries citing papers authored by Paolo Cameli

Since Specialization

Citations

This map shows the geographic impact of Paolo Cameli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Cameli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Cameli more than expected).

Fields of papers citing papers by Paolo Cameli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Cameli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Cameli. The network helps show where Paolo Cameli may publish in the future.

Co-authorship network of co-authors of Paolo Cameli

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Cameli. A scholar is included among the top collaborators of Paolo Cameli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Cameli. Paolo Cameli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iovene, Bruno, et al.. (2025). A Simple Ratio in a Complex Disease: Exploring the Neutrophil-to-Lymphocyte Ratio in Idiopathic Pulmonary Fibrosis. Journal of Clinical Medicine. 14(14). 5100–5100. 1 indexed citations

d’Alessandro, Miriana, Edoardo Conticini, Laura Bergantini, et al.. (2024). Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of interstitial lung disease. Tissue and Cell. 90. 102516–102516.

Hernández‐González, Fernanda, Federico Pietrocola, Paolo Cameli, et al.. (2024). Exploring the Interplay between Cellular Senescence, Immunity, and Fibrosing Interstitial Lung Diseases: Challenges and Opportunities. International Journal of Molecular Sciences. 25(14). 7554–7554. 5 indexed citations

Soccio, Piera, Miriana d’Alessandro, Giulia Scioscia, et al.. (2024). Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis. Biomedicines. 12(2). 269–269. 5 indexed citations

Bergantini, Laura, et al.. (2023). Predictive Role of Cytokine and Adipokine Panel in Hospitalized COVID-19 Patients: Evaluation of Disease Severity, Survival and Lung Sequelae. International Journal of Molecular Sciences. 24(16). 12994–12994. 8 indexed citations

d’Alessandro, Miriana, Piera Soccio, Elisabet Cantó, et al.. (2023). The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study. International Journal of Molecular Sciences. 24(4). 4071–4071. 5 indexed citations

Bergantini, Laura, et al.. (2022). Combined Sarcoidosis and Idiopathic Pulmonary Fibrosis (CSIPF): A New Phenotype or a Fortuitous Overlap? Scoping Review and Case Series. Journal of Clinical Medicine. 11(7). 2065–2065. 9 indexed citations

Bergantini, Laura, Miriana d’Alessandro, Giuseppe Campiani, et al.. (2022). Bronchoalveolar-Lavage-Derived Fibroblast Cell Line (B-LSDM7) as a New Protocol for Investigating the Mechanisms of Idiopathic Pulmonary Fibrosis. Cells. 11(9). 1441–1441. 3 indexed citations

Cameli, Paolo, Paola Faverio, Stefania Marsili, et al.. (2022). Immune-Checkpoint-Inhibitor-Related Lung Toxicity: A Multicentre Real-Life Retrospective Portrait from Six Italian Centres. Life. 12(8). 1149–1149. 4 indexed citations

10.

d’Alessandro, Miriana, Laura Bergantini, Paolo Cameli, et al.. (2022). Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II. International Journal of Environmental Research and Public Health. 19(4). 2176–2176. 6 indexed citations

11.

d’Alessandro, Miriana, Laura Bergantini, Paolo Cameli, et al.. (2021). Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy. Cancers. 13(4). 689–689. 39 indexed citations

12.

Bergantini, Laura, et al.. (2021). NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19. Cells. 10(11). 3182–3182. 23 indexed citations

13.

d’Alessandro, Miriana, Piera Soccio, Laura Bergantini, et al.. (2021). Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach. Cells. 10(5). 1045–1045. 21 indexed citations

14.

Cameli, Paolo, Maria Concetta Pastore, Giulia Elena Mandoli, et al.. (2021). Strain Echocardiography Is a Promising Tool for the Prognostic Assessment of Sarcoidosis. Life. 11(10). 1065–1065. 3 indexed citations

15.

Sartorelli, Pietro, Francesco Bianchi, Miriana d’Alessandro, et al.. (2020). Cytological analysis of bronchoalveolar lavage fluid in asbestos-exposed workers. La Medicina del lavoro. 111(5). 379–387. 7 indexed citations

16.

Mandoli, Giulia Elena, Maria Concetta Pastore, Paolo Cameli, et al.. (2020). Speckle tracking stress echocardiography: A valuable diagnostic technique or a burden for everyday practice?. Echocardiography. 37(12). 2123–2129. 10 indexed citations

17.

Sisti, Nicolò, Serafina Valente, Giulia Elena Mandoli, et al.. (2020). COVID-19 in patients with heart failure: the new and the old epidemic. Postgraduate Medical Journal. 97(1145). 175–179. 30 indexed citations

18.

Pastore, Maria Concetta, Giulia Elena Mandoli, Hatem Soliman-Aboumarie, et al.. (2019). Basic and advanced echocardiography in advanced heart failure: an overview. Heart Failure Reviews. 25(6). 937–948. 44 indexed citations

19.

Bennett, David, Annalisa Fui, Giuseppe Cillis, et al.. (2019). Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP. Inflammation. 42(2). 463–470. 37 indexed citations

20.

Cameli, Paolo, et al.. (2016). Exhaled nitric oxide is not increased in pulmonary sarcoidosis.. PubMed. 33(1). 39–40. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact